BAXTER HEALTHCARE CORPORATION for BAXTER HEALTHCARE CORPORATION

Trade (domestic/foreign) TRD

The Miscellaneous Tariff Bill

Contacted: SENATE; Natl Economic Council (NEC); Homeland Security, Dept of (DHS); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

H.R. 3200, America's Affordable Health Choices Act of 2009/ "America's Healthy Future Act" (unnumbered Senate bill), as it relates to new fees on manufacturers of drugs and medical devices and to taxation of employer-sponsored health coverage. Issues related to the taxation of foreign earnings of U.S. multinational corporations

Contacted: Natl Economic Council (NEC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 3200 (111th)

Copyright/Patent/Trademark CPT

S.515/S. 610/H.R. 1260: Patent Reform Act of 2009, all issues related to patent reform.

Contacted: Centers For Medicare and Medicaid Services (CMS); Homeland Security, Dept of (DHS); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS)

Bills named: S. 610 (111th), H.R. 1260 (111th), S. 515 (111th)

Health Issues HCR

H.R. 6331 (110th Congress): To amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare Program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes. In particular, execution of the kidney education and bundling provisions. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. H.R.1: The American Recovery and Reinvestment Act (stimulus bill); Specifically focused on aspects of the bill related to comparative effectiveness research. H.R.1548 : To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes. H.R.2502 : To amend title XI of the Social Security Act to provide for the conduct of comparative effectiveness research and to amend the Internal Revenue Code of 1986 to establish a Comparative Effectiveness Research Trust Fund, and for other purposes. S. 1679: An original bill to make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce. H.R.1085/S. 442: To impose a limitation on lifetime aggregate limits imposed by health plans H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. "America's Healthy Future Act" (unnumbered Senate bill), as it relates to Medicaid reimbursement for drugs and new fees on manufacturers of drugs and medical devices. Drug and device marketing and promotion Drug and biological product pricing and reimbursement Drug and biological product pricing and reimbursement Healthcare-acquired infections Issues regarding 340B Lifetime caps for insurance Medical product safety Prescription drug pedigree and anti-counterfeiting policy

Contacted: Natl Economic Council (NEC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Homeland Security, Dept of (DHS)

Bills named: S. 442 (111th), H.R. 1085 (111th), H.R. 6331 (111th), H.R. 2502 (111th), H.R. 1 (111th), H.R. 1548 (111th), H.R. 759 (111th), H.R. 2726 (111th), S. 1679 (111th)

Medicare/Medicaid MMM

H.R. 3200: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. S. 301: A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP. H.R.1765 : To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program. S.701: A bill to amend title XVIII of the Social Security Act to improve access of Medicare beneficiaries to intravenous immune globulins (IVIG). "America's Healthy Future Act" (unnumbered Senate bill), as it relates to Medicaid reimbursement for drugs and new fees on manufacturers of drugs and medical devices. H.R. 6331 (110th Congress): To amend titles XVIII and XIX of the Social Security Act to extend expiring provisions under the Medicare Program, to improve beneficiary access to preventive and mental health services, to enhance low-income benefit programs, and to maintain access to care in rural areas, including pharmacy access, and for other purposes. In particular, execution of the kidney education and bundling provisions. Product Payment Issues Therapy Payment Issues

Contacted: Natl Economic Council (NEC); Homeland Security, Dept of (DHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS)

Bills named: H.R. 6331 (111th), S. 701 (111th), H.R. 3200 (111th), H.R. 1765 (111th), S. 301 (111th)